BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35660026)

  • 21. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Functional Relationship Between UNC45A and MYO5B Connects Two Rare Diseases With Shared Enteropathy.
    Li Q; Zhou Z; Sun Y; Sun C; Klappe K; van IJzendoorn SCD
    Cell Mol Gastroenterol Hepatol; 2022; 14(2):295-310. PubMed ID: 35421597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects.
    Forteza R; Ahsan MK; Cartón-García F; Arango D; Ameen NA; Salas PJ
    Mol Biol Cell; 2019 Dec; 30(26):3076-3089. PubMed ID: 31664880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of Serum Glucocorticoid-Inducible Kinase 1 SGK1 Worsens Malabsorption and Diarrhea in Microvillus Inclusion Disease (MVID).
    Ahsan MK; Dos Reis DC; Barbieri A; Sumigray KD; Nottoli T; Salas PJ; Ameen NA
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease.
    Vogel GF; Janecke AR; Krainer IM; Gutleben K; Witting B; Mitton SG; Mansour S; Ballauff A; Roland JT; Engevik AC; Cutz E; Müller T; Goldenring JR; Huber LA; Hess MW
    Traffic; 2017 Jul; 18(7):453-464. PubMed ID: 28407399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.
    Kalashyan M; Raghunathan K; Oller H; Bayer MT; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37643022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease.
    Jayawardena D; Alrefai WA; Dudeja PK; Gill RK
    F1000Res; 2019; 8():. PubMed ID: 31824659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel
    Hassan K; Robay A; Al-Maraghi A; Nimeri N; Azzam AB; Al Shakaki A; Hamid E; Crystal RG; Fakhro KA
    Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 34815247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The zebrafish goosepimples/myosin Vb mutant exhibits cellular attributes of human microvillus inclusion disease.
    Sidhaye J; Pinto CS; Dharap S; Jacob T; Bhargava S; Sonawane M
    Mech Dev; 2016 Nov; 142():62-74. PubMed ID: 27497746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of MYO5B in mice recapitulates Microvillus Inclusion Disease and reveals an apical trafficking pathway distinct to neonatal duodenum.
    Weis VG; Knowles BC; Choi E; Goldstein AE; Williams JA; Manning EH; Roland JT; Lapierre LA; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2016 Feb; 2(2):131-157. PubMed ID: 27019864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cargo-selective apical exocytosis in epithelial cells is conducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3.
    Vogel GF; Klee KM; Janecke AR; Müller T; Hess MW; Huber LA
    J Cell Biol; 2015 Nov; 211(3):587-604. PubMed ID: 26553929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.
    Müller T; Hess MW; Schiefermeier N; Pfaller K; Ebner HL; Heinz-Erian P; Ponstingl H; Partsch J; Röllinghoff B; Köhler H; Berger T; Lenhartz H; Schlenck B; Houwen RJ; Taylor CJ; Zoller H; Lechner S; Goulet O; Utermann G; Ruemmele FM; Huber LA; Janecke AR
    Nat Genet; 2008 Oct; 40(10):1163-5. PubMed ID: 18724368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncovering the Relationship Between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease.
    Sun M; Pylypenko O; Zhou Z; Xu M; Li Q; Houdusse A; van IJzendoorn SCD
    Cell Mol Gastroenterol Hepatol; 2024; 17(6):983-1005. PubMed ID: 38307491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of syntaxin 3 causes variant microvillus inclusion disease.
    Wiegerinck CL; Janecke AR; Schneeberger K; Vogel GF; van Haaften-Visser DY; Escher JC; Adam R; Thöni CE; Pfaller K; Jordan AJ; Weis CA; Nijman IJ; Monroe GR; van Hasselt PM; Cutz E; Klumperman J; Clevers H; Nieuwenhuis EE; Houwen RH; van Haaften G; Hess MW; Huber LA; Stapelbroek JM; Müller T; Middendorp S
    Gastroenterology; 2014 Jul; 147(1):65-68.e10. PubMed ID: 24726755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: A mutation update.
    Dhekne HS; Pylypenko O; Overeem AW; Zibouche M; Ferreira RJ; van der Velde KJ; Rings EHHM; Posovszky C; van der Sluijs P; Swertz MA; Houdusse A; van IJzendoorn SCD
    Hum Mutat; 2018 Mar; 39(3):333-344. PubMed ID: 29266534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trafficking Ion Transporters to the Apical Membrane of Polarized Intestinal Enterocytes.
    Engevik AC; Goldenring JR
    Cold Spring Harb Perspect Biol; 2018 Jan; 10(1):. PubMed ID: 28264818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraintestinal manifestations in an infant with microvillus inclusion disease: complications or features of the disease?
    Siahanidou T; Koutsounaki E; Skiathitou AV; Stefanaki K; Marinos E; Panajiotou I; Chouliaras G
    Eur J Pediatr; 2013 Sep; 172(9):1271-5. PubMed ID: 23354788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical features and MYO5B mutations of a family affected by microvillus inclusion disease].
    Cheng Y; Liang H; Cai NL; Guo L; Huang YG; Song YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Sep; 19(9):968-974. PubMed ID: 28899465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy Development for Microvillus Inclusion Disease using Patient-derived Enteroids.
    Kalashyan M; Raghunathan K; Oller H; Theres MB; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR
    bioRxiv; 2023 Jan; ():. PubMed ID: 36747680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myosin Vb and Rab11a regulate phosphorylation of ezrin in enterocytes.
    Dhekne HS; Hsiao NH; Roelofs P; Kumari M; Slim CL; Rings EH; van Ijzendoorn SC
    J Cell Sci; 2014 Mar; 127(Pt 5):1007-17. PubMed ID: 24413175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.